Clopidogrel does not optimally inhibit platelet aggregation in patients undergoing percutaneous coronary intervention. Observations from the DEACON study

被引：0
|
作者：
Saucedo, JF
Aude, W
Garza, L
机构：
[1] Univ Oklahoma, HSC, Oklahoma City, OK USA
[2] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 92卷 / 6A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10L / 11L
页数：2
相关论文
共 50 条
  • [41] Effect of cilostazol addition or clopidogrel doubling on platelet function profiles in diabetic patients undergoing a percutaneous coronary intervention
    Ha, Sang Jin
    Kim, Soo-Joong
    Hwang, Seok-Jae
    Woo, Jong Shin
    Kim, Weon
    Kim, Woo-Shik
    Kim, Kwon Sam
    Kim, Myeong Kon
    CORONARY ARTERY DISEASE, 2013, 24 (08) : 690 - 697
  • [42] Impact of Chronic Kidney Disease on Platelet Reactivity and Outcomes of Patients Receiving Clopidogrel and Undergoing Percutaneous Coronary Intervention
    Mangiacapra, Fabio
    Cavallari, Ilaria
    Barbato, Emanuele
    Ricottini, Elisabetta
    Patti, Giuseppe
    Vizzi, Vincenzo
    D'Ambrosio, Andrea
    De Bruyne, Bernard
    Wijns, William
    Di Sciascio, Germano
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (07): : 1124 - 1129
  • [43] Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention.
    Jurado, Alfonso
    Hernandez, Felipe
    Garcia-Tejada, Julio
    Albarran, Agustin
    Teresa Velazquez, M.
    Granda, Carolina
    Belen, Diaz
    Rubio, Belen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B109 - B109
  • [44] Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Norgard, Nicholas B.
    Abu-Fadel, Mazen
    VASCULAR HEALTH AND RISK MANAGEMENT, 2009, 5 : 873 - 882
  • [45] Abciximab reduces procedure time among patients undergoing percutaneous coronary intervention.
    Cabot, CF
    Anderson, KM
    Tcheng, JE
    Lincoff, AM
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (6A): : 71P - 71P
  • [46] Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention
    Yudi, M. B.
    Clark, D. J.
    Farouque, O.
    Eccleston, D.
    Andrianopoulos, N.
    Duffy, S. J.
    Brennan, A.
    Lefkovits, J.
    Ramchand, J.
    Yip, T.
    Oqueli, E.
    Reid, C. M.
    Ajani, A. E.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (05) : 559 - 565
  • [47] Prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention
    Deepak L. Bhatt
    Current Atherosclerosis Reports, 2008, 10 (5) : 367 - 368
  • [48] How Long Does It Take for Clopidogrel and Ticagrelor to Inhibit Platelets in Patients Undergoing Primary Percutaneous Coronary Intervention? A Detailed Pharmacodynamic Analysis: Time Course of Platelet Reactivity in STEMI (TOPS)
    Bergmeijer, Thomas O.
    Godschalk, Thea C.
    Janssen, Paul W. A.
    van den Berge, Kim
    Breet, Nicoline J.
    Kelder, Johannes C.
    Hackeng, Christian M.
    Ten Berg, Jurrien M.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (04): : 439 - 446
  • [49] Sustained benefit of fenoldopam on renal function in patients undergoing percutaneous coronary intervention.
    Kini, AS
    Agarwal, A
    Mukaddam, S
    Lee, P
    Mitre, CA
    Attanti, S
    Duffy, ME
    Kim, MC
    Sharma, SK
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (6A): : 144H - 145H
  • [50] Impact of Anemia on Platelet Response to Clopidogrel in Patients Undergoing Percutaneous Coronary Stenting
    Toma, Catalin
    Zahr, Firas
    Moguilanski, Diego
    Grate, Sheree
    Semaan, Roy W.
    Lemieux, Nicole
    Lee, Joon S.
    Cortese-Hassett, Andrea
    Mulukutla, Suresh
    Rao, Sunil V.
    Marroquin, Oscar C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (08): : 1148 - 1153
12345